148 related articles for article (PubMed ID: 35852618)
1. KNTC1 as a putative tumor oncogene in pancreatic cancer.
Liu L; Chen H; Chen X; Yao C; Shen W; Jia C
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3023-3031. PubMed ID: 35852618
[TBL] [Abstract][Full Text] [Related]
2. The role of KNTC1 in the regulation of proliferation, migration and tumorigenesis in colorectal cancer.
Wang J; Ding Z; Shu W; Zhuge Y
Cell Signal; 2023 Aug; 108():110728. PubMed ID: 37230198
[TBL] [Abstract][Full Text] [Related]
3. shRNA‑mediated knockdown of KNTC1 suppresses cell viability and induces apoptosis in esophageal squamous cell carcinoma.
Liu CT; Min L; Wang YJ; Li P; Wu YD; Zhang ST
Int J Oncol; 2019 Mar; 54(3):1053-1060. PubMed ID: 30628654
[TBL] [Abstract][Full Text] [Related]
4. Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9.
Wang C; Wang Y; Liu C; Meng X; Hang Z
Bioengineered; 2022 Apr; 13(4):9495-9507. PubMed ID: 35389773
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of KNTC1 Inhibits the Proliferation, Migration and Tumorigenesis of Human Bladder Cancer Cells and Induces Apoptosis.
Huang H; Fan X; Qiao Y; Yang M; Ji Z
Crit Rev Eukaryot Gene Expr; 2021; 31(1):49-60. PubMed ID: 33639055
[TBL] [Abstract][Full Text] [Related]
6. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.
Tong H; Liu X; Peng C; Shen B; Zhu Z
Cell Signal; 2023 Jan; 101():110498. PubMed ID: 36273753
[TBL] [Abstract][Full Text] [Related]
7. shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8.
Liu R; Liu R; Guo Z; Ren J; Huang J; Luo Q; Tan Q
Cell Death Dis; 2022 Aug; 13(8):685. PubMed ID: 35933405
[TBL] [Abstract][Full Text] [Related]
8. KNTC1, regulated by HPV E7, inhibits cervical carcinogenesis partially through Smad2.
Pan W; Wang S; Liu X; Wang M; Han X; Tian X; Lin J; Qiao X; Wang X
Exp Cell Res; 2023 Feb; 423(1):113458. PubMed ID: 36608837
[TBL] [Abstract][Full Text] [Related]
9. KNTC1 knockdown suppresses cell proliferation of colon cancer.
Zhengxiang Z; Yunxiang T; Zhiping L; Zhimin Y
3 Biotech; 2021 Jun; 11(6):262. PubMed ID: 33996374
[TBL] [Abstract][Full Text] [Related]
10. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.
Jiang C; Yi XP; Shen H; Li YX
World J Gastroenterol; 2012 Jun; 18(23):2956-65. PubMed ID: 22736919
[TBL] [Abstract][Full Text] [Related]
11. High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells.
Li WG; Yuan YZ; Qiao MM; Zhang YP
World J Gastroenterol; 2012 Jun; 18(21):2630-9. PubMed ID: 22690071
[TBL] [Abstract][Full Text] [Related]
12. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
Zhu H; Qin H; Li DM; Liu J; Zhao Q
Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
[TBL] [Abstract][Full Text] [Related]
13. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
[TBL] [Abstract][Full Text] [Related]
14. siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo.
Hu P; Chen X; Sun J; Bie P; Zhang LD
Biosci Rep; 2015 Jan; 35(1):. PubMed ID: 25370920
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo.
Guo J; Gao J; Li Z; Gong Y; Man X; Jin J; Wu H
Cancer Lett; 2013 Oct; 339(2):185-94. PubMed ID: 23791879
[TBL] [Abstract][Full Text] [Related]
16. KNTC1 knockdown inhibits proliferation and metastases of liver cancer.
Yang F; Yuan C
3 Biotech; 2023 Sep; 13(9):309. PubMed ID: 37621322
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
[TBL] [Abstract][Full Text] [Related]
18. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
[TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant Transformation via Inhibition of STIL in Pancreatic Cancer.
Ye Z; Zhu Z; Xie J; Feng Z; Li Y; Xu X; Li W; Chen W
Int J Nanomedicine; 2020; 15():9859-9873. PubMed ID: 33324055
[TBL] [Abstract][Full Text] [Related]
20. [Protocadherin 10 (PCDH10) inhibits the proliferation, invasion and migration ability of BXPC-3 pancreatic cancer cells].
Qiu C; Bu X; Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):163-7. PubMed ID: 26927373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
